Prodia Diagnostic Line is trading 10.8% down today at IDR 248 as selling pressure continues following its recent IPO.
- Investors are locking in gains after sharp early advances, leading to a normalization phase following the initial July IPO volatility.
- The decline appears to be a company-specific dynamic rather than sector-wide weakness, as broader healthcare benchmarks remain in positive territory.